Commission Implementing Regulation (EU) 2017/1527 of 6 September 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances cyflufenamid, fluopicolide, heptamaloxyloglucan and malathion (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2017/1527
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 296, Cyflufenamid, the date is replaced by ‘31 March 2023’;

(2)

in the sixth column, expiration of approval, of row 297, Fluopicolide, the date is replaced by ‘31 May 2023’;

(3)

in the sixth column, expiration of approval, of row 298, Heptamaloxyloglucan, the date is replaced by ‘31 May 2021’;

(4)

in the sixth column, expiration of approval, of row 300, Malathion, the date is replaced by ‘30 April 2022’.